AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|AAPL334.51+2.24 (+0.67%) ▲|ABBV261.68+4.56 (+1.77%) ▲|ABT102.73+0.78 (+0.77%) ▲|ACN194.40+10.50 (+5.71%) ▲|ADBE263.56+11.33 (+4.49%) ▲|AMAT426.19-30.30 (-6.64%) ▼|AMD495.42-20.71 (-4.01%) ▼|AMGN380.80+3.45 (+0.91%) ▲|AMT177.21-0.65 (-0.36%) ▼|AMZN253.96-2.82 (-1.10%) ▼|AVGO344.37-17.63 (-4.87%) ▼|AXP327.64+2.95 (+0.91%) ▲|BA209.92-0.54 (-0.25%) ▼|BAC59.40-3.30 (-5.26%) ▼|BKNG175.50+1.58 (+0.91%) ▲|BLK1,066.15-13.50 (-1.25%) ▼|BMY64.04+0.40 (+0.63%) ▲|BNY157.59-5.07 (-3.12%) ▼|BRK-B515.18+4.81 (+0.94%) ▲|C137.11-1.71 (-1.23%) ▼|CAT784.88-33.69 (-4.12%) ▼|CL88.27+1.47 (+1.69%) ▲|CMCSA24.89-0.32 (-1.25%) ▼|COF207.02-1.29 (-0.62%) ▼|COP136.34-1.01 (-0.74%) ▼|COST920.04+15.27 (+1.69%) ▲|CRM259.43+11.71 (+4.73%) ▲|CSCO110.31-1.82 (-1.62%) ▼|CVS95.76+1.10 (+1.16%) ▲|CVX211.80-2.26 (-1.06%) ▼|DE680.83+5.09 (+0.75%) ▲|DHR202.76+2.62 (+1.31%) ▲|DIS108.79+2.24 (+2.10%) ▲|DUK118.88-0.54 (-0.45%) ▼|EMR148.27-3.92 (-2.58%) ▼|FDX312.06+1.29 (+0.42%) ▲|GD357.32+1.42 (+0.40%) ▲|GE317.53-6.13 (-1.89%) ▼|GEV873.21-84.06 (-8.78%) ▼|GILD146.23+2.51 (+1.75%) ▲|GM87.09+1.47 (+1.72%) ▲|GOOG344.74+9.29 (+2.77%) ▲|GOOGL348.22+9.72 (+2.87%) ▲|GS989.32-39.86 (-3.87%) ▼|HD311.65+2.91 (+0.94%) ▲|HON201.22-1.15 (-0.57%) ▼|IBM249.31+6.02 (+2.47%) ▲|INTC97.54-5.41 (-5.25%) ▼|INTU339.28+17.71 (+5.51%) ▲|ISRG378.26+9.11 (+2.47%) ▲|JNJ267.06+1.48 (+0.56%) ▲|JPM350.09-6.14 (-1.72%) ▼|KO89.24+0.95 (+1.07%) ▲|LIN463.08-3.14 (-0.67%) ▼|LLY1,138.90+23.20 (+2.08%) ▲|LMT530.83+6.64 (+1.27%) ▲|LOW198.79+1.97 (+1.00%) ▲|LRCX274.88-23.34 (-7.83%) ▼|MA572.51+3.32 (+0.58%) ▲|MCD257.40+4.87 (+1.93%) ▲|MDLZ62.31-0.14 (-0.22%) ▼|MDT93.74+2.78 (+3.05%) ▲|META666.95+18.92 (+2.92%) ▲|MMM162.12-2.85 (-1.73%) ▼|MO70.60+1.62 (+2.34%) ▲|MRK144.64+0.71 (+0.49%) ▲|MS207.34-7.05 (-3.29%) ▼|MSFT507.36+11.73 (+2.37%) ▲|MU927.33-47.93 (-4.91%) ▼|NEE81.77-0.54 (-0.66%) ▼|NFLX80.41+3.01 (+3.89%) ▲|NKE37.05+0.25 (+0.68%) ▲|NOW142.45+9.92 (+7.48%) ▲|NVDA211.77-6.52 (-2.99%) ▼|ORCL143.52-6.77 (-4.50%) ▼|PEP136.41+0.09 (+0.07%) ▲|PFE27.74+0.02 (+0.07%) ▲|PG146.09+0.82 (+0.56%) ▲|PLTR173.86+6.63 (+3.96%) ▲|PM194.39+3.33 (+1.74%) ▲|QCOM180.40-1.57 (-0.86%) ▼|RTX195.05-2.64 (-1.33%) ▼|SBUX99.12+0.38 (+0.38%) ▲|SCHW107.25+0.00 (+0.00%) ▲|SO86.77-0.40 (-0.46%) ▼|SPG204.77-0.06 (-0.03%) ▼|T26.57+0.51 (+1.94%) ▲|TMO611.41+1.59 (+0.26%) ▲|TMUS182.41+0.08 (+0.04%) ▲|TSLA360.37-5.07 (-1.39%) ▼|TXN263.76-4.95 (-1.84%) ▼|UBER72.57+0.90 (+1.25%) ▲|UNH383.76+6.99 (+1.86%) ▲|UNP284.89+0.49 (+0.17%) ▲|UPS102.33+2.05 (+2.04%) ▲|USB62.62-0.23 (-0.36%) ▼|V374.27+3.82 (+1.03%) ▲|VZ51.33+0.72 (+1.43%) ▲|WFC88.60-1.69 (-1.87%) ▼|WMT109.53+2.38 (+2.22%) ▲|XOM164.53-1.46 (-0.88%) ▼|
23.9 C
New York
Monday, September 14, 2026

Tag: report

The Villages Health (“TVH”) Announces Strategic Restructuring and Agreement to be Acquired by CenterWell

ORLANDO, Fla., July 3, 2025 /PRNewswire/ -- The Villages Health ("TVH"), the trusted healthcare system for The Villages retirement community in Florida, today announced...

Aura Minerals Announces Filing of Early Warning Report Regarding Altamira Gold Corp.

ROAD TOWN, British Virgin Islands, July 3, 2025 /CNW/ - Aura Minerals Inc. (TSX: ORA) (B3: AURA33) and (OTCQX: ORAAF) ("Aura" or the "Company") announced...

PUDO Inc announces earnings call for Q1 FY 2026 – save the date

TORONTO, July 3, 2025 /CNW/ - PUDO Inc. ("PUDO" or the "Company") (CSE: PDO) (OTCQB: PDPTF), today announced that it will report its first...

Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide

In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.
In this 2025 availability update, Remote Pharmacy highlights the expanded access to non-branded GLP-1-based weight management options, including semaglutide and tirzepatide compounds. The release explores the evolving role of compounded therapeutics, shifts in consumer behavior toward remote prescribing, and how new formulations align with the growing interest in safe, physician-directed care for weight management.

NeuroEnergizer 2025 Update Positions OTC Audio Program at Forefront of Cognitive Wellness Movement

Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.
Binaural beat-based audio suite supports focus, rest, and digital clarity with a non-invasive, non-clinical format—now updated for 2025.

Cascadia Announces Closing of Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ VANCOUVER, BC, July 3, 2025 /CNW/ - Cascadia Minerals Ltd. ("Cascadia")...

BUTLER NATIONAL CORPORATION ANNOUNCES FISCAL YEAR END 2025 FINANCIAL RESULTS

-Record earnings increasing to $0.19 per share -Record operating income of $16.8 million, reflecting a 27% increase from prior year OLATHE, Kan., July 3, 2025 /PRNewswire/...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

GPRC5D-directed Therapies Market is Anticipated to Gain Momentum During the Forecast Period (2025-2034) Owing to Unmet Need in Multiple Myeloma | DelveInsight

The GPRC5D-directed therapies market is witnessing robust growth, driven by the high unmet need in relapsed/refractory multiple myeloma. Innovative modalities like CAR-T cells, bispecific...

Theratechnologies to Announce Second Quarter 2025 Financial Results

MONTREAL, July 03, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, today announced the Company will report financial results for its second quarter 2025 ended May 31 on Wednesday, July 9, 2025.

The Early Care & Education Consortium Applauds Congress for Enhancing Critical Child Care Tax Incentives

WASHINGTON, July 3, 2025 /PRNewswire/ -- The Early Care and Education Consortium (ECEC) applauds Congress for including $16 billion in child care tax incentives...

BLUE & CO., LLC PROVIDES NOTICE OF DATA EVENT

CARMEL, Ind., July 3, 2025 /PRNewswire/ -- Blue & Co., LLC ("Blue") is a financial consultant for companies and is providing notice of an...

Contact Levi & Korsinsky by August 11, 2025 Deadline to Join Class Action Against Rocket Pharmaceuticals, Inc. (RCKT)

NEW YORK, July 03, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, July 03, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on July 1, 2025 (the “Grant Date”), ORIC granted a total of 9,000 non-qualified stock options and 1,600 restricted stock units to one new non-executive employee who began their employment with ORIC in June 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsReport